Biocartis and Amgen Shake Hands on Another Cancer Diagnostics Deal
Biocartis will use its expertise in molecular diagnostics to produce a companion diagnostic test for…
Biocartis will use its expertise in molecular diagnostics to produce a companion diagnostic test for…
Immatics has completed a $58M (€50M) round with the participation of Amgen, not long after both…
Elasmogen and its partner Feldan Therapeutics have signed a research agreement with Amgen to develop…
Amgen and Novartis have expanded their collaboration for the co-development of their migraine drug, ensuring…
Patrick Baeuerle is the German biotech leader I wanted to interview the most (besides Simon…
Immatics and Amgen have inked a deal to develop bispecific drug candidates for cancer that…
Genomics Medicine Ireland (GMI) has raised €36M ($40M) in series A to sequence the genome of…
The giant Amgen has offered Nuevolution €365M to develop oncology and neuroscience drugs. The small Danish…
Genenta Science and Amgen have teamed up to develop gene therapies for cancer. The Italian…
4SC, in Germany, has the FDA's green light to conduct efficacy trials in the US…
UCB (Belgium) has a monoclonal antibody candidate (romozumab) which has met its primary endpoints for a…
Blincyto (Blinatumomab) is the first bispecific antibody construct from Amgen’s BiTE proprietary platform to be…